Traveler’s Diarrhea Market Outlook: Traveler’s Diarrhea Market anticipated to increase from USD 1,717 USD in 2017 in 7MM

Traveler’s Diarrhea Market Outlook: Traveler’s Diarrhea Market anticipated to increase from USD 1,717 USD in 2017 in 7MM

“Traveler’s Diarrhea Market Insights”
DelveInsight’s “Traveler’s Diarrhea – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Traveler’s Diarrhea, historical and forecasted epidemiology as well as the Traveler’s Diarrhea market trends. The Traveler’s Diarrhea market report provides current treatment practices, emerging drugs, Traveler’s Diarrhea market share of the individual therapies, current and forecasted Traveler’s Diarrhea market Size from 2017 to 2030.

DelveInsight’s “Traveler’s Diarrhea – Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Traveler’s Diarrhea, historical and forecasted epidemiology as well as the Traveler’s Diarrhea market trends.

Study Period: 2017-30

Geographies Covered

  • The United States,
  • EU5 (Germany, Spain, Italy, France, and United Kingdom)
  • Japan

The DelveInsight Traveler’s Diarrhea market report gives a thorough understanding of the Traveler’s Diarrhea by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Traveler’s Diarrhea (TD) is an intestinal infection, a digestive tract disorder that is caused by a variety of pathogens but most commonly by bacteria found in food and water, often related to poor hygiene practices. Being the most predictable disease, around 30% to 70% of the travelers are found to suffer from it.

Traveler’s Diarrhea Epidemiology

DelveInsight’s assessment based on the recent studies and data from registries shows that the European 5 countries and US accounts for the 43.4% and 40.77% of the total Incident cases out of all the TD cases in 7 major markets in 2017.

The Traveler’s Diarrhea epidemiology division provide insights about historical and current Traveler’s Diarrhea patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.

As per DelveInsight’s estimates, in 2017 only the European 5 countries and the US accounted for about 43.4% and 40.77% of the total Traveler’s Diarrhea Incident cases out of all the TD cases in 7 major markets.

Traveler’s Diarrhea Epidemiology Segmentation

  • Total Traveler’s Diarrhea Incident Cases
  • Total Diagnosed Traveler’s Diarrhea Incident Cases
  • Severity-Specific Diagnosed Traveler’s Diarrhea Incident Cases

Traveler’s Diarrhea treatment Market

The Traveler’s Diarrhea Treatment Market comprises of anti-motility drugs or Antidiarrheal drugs (also known as symptomatic therapy) including bismuth subsalicylate and Synthetic opiates such as loperamide and diphenoxylate, with ciprofloxacin, ofloxacin, norfloxacin and levofloxacin and Dukarol (Vaccine) dominating the market as first line of therapy.

Visit to know more.

Traveler’s Diarrhea Market Outlook

According to DelveInsight, Traveler’s Diarrhea market in 7MM is expected to increase in the study period 2017-2030 from USD 1,717 Million in 2017. The United States accounts for the largest Traveler’s Diarrhea market size, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan owing to the largest number of incident population.

The Traveler’s Diarrhea market report provides current treatment practices, emerging drugs, Traveler’s Diarrhea market share of the individual therapies, current and forecasted Traveler’s Diarrhea market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Traveler’s Diarrhea treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Key pharma players such as Scandinavian Biopharma, Procter and Gamble, and others have the potential to create a significant positive shift in the Traveler’s Diarrhea Market Size.

Request for sample pages.

Traveler’s Diarrhea Pipeline Drugs

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Traveler’s Diarrhea key players involved in developing targeted therapeutics. 

The late stage product Bismuth Subsalicylate has emerged as a promising option to enter the market in 2021 for Traveler’s Diarrhea. Another mid stage product Etvax is a vaccine against diarrheal disease caused by ETEC expected to enter the market by 2023.

 

Scope of the report

  • Descriptive overview of Traveler’s Diarrhea, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Traveler’s Diarrhea epidemiology and treatment in the 7MM
  • In-depth account of both the current and emerging therapies for Traveler’s Diarrhea along with the assessment of new therapies
  • Detailed review of Traveler’s Diarrhea market; historical and forecasted

 

Table of Contents

1. Key Insights

2. Executive Summary of Traveler’s Diarrhea

3. Competitive Intelligence Analysis for Traveler’s Diarrhea

4. Traveler’s Diarrhea: Market Overview at a Glance

5. Traveler’s Diarrhea: Disease Background and Overview

6. Patient Journey

7. Traveler’s Diarrhea Epidemiology and Patient Population

9. Unmet Needs

10. Key Endpoints of Traveler’s Diarrhea Treatment

12. Emerging Therapies

13. Traveler’s Diarrhea: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Traveler’s Diarrhea

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary.

 

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.  

Browse through our vast repository

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
Country: United States
Website: www.delveinsight.com/